Indiana Medical Spa Advertising Compliance

TL;DR: Medical spa advertising in Indiana is now governed by a three-board regulatory framework created by Senate Enrolled Act 282 (2026). Beginning January 1, 2027, every registered medical spa must comply with Indiana’s statewide health care provider advertising statute — IC 25-1-10.3 — along with the Medical Licensing Board’s conduct rules, the Indiana Board of Pharmacy’s compounded-drug promotion standards, and the State Board of Cosmetology & Barber Examiners’ licensee requirements. Advertising violations can trigger registration suspension under IC 25-22.5-12.5-6, individual license discipline under IC 25-1-9-4, and civil penalties reaching $5,000 per violation. Operators should begin their advertising compliance review now — before the January 2027 enforcement deadline.

Indiana’s medical spa industry is booming — and so is the regulatory attention that comes with it. Senate Enrolled Act 282, signed into law by Governor Braun on March 5, 2026, transforms medical spas from loosely supervised facilities into formally registered healthcare entities under the joint oversight of three distinct licensing boards. For operators, the stakes of medical spa advertising in Indiana have never been higher.

What many spa owners and responsible practitioners don’t yet appreciate is that advertising is the most visible, most easily documented, and most frequently disciplined surface on which compliance failures appear. A single misleading social media post, a misstated provider credential, or an improper claim about a compounded drug product can simultaneously put a facility registration, a physician’s license, and an esthetician’s certification at risk. This post breaks down the framework, identifies the most common pitfalls, and explains what operators must do before the January 1, 2027 enforcement deadline.

The Medical Spa Advertising Hook: What IC 25-22.5-12.5-8 Actually Does

The linchpin of the new advertising framework is deceptively short. IC 25-22.5-12.5-8 states that a medical spa shall comply with the advertising requirements set forth in IC 25-1-10.5 — Indiana’s statewide health care provider advertising statute. By incorporating that chapter by reference, the legislature subjected the spa as a registered entity — not merely the individual practitioners working within it — to advertising rules that previously applied only to individual licensees.

The practical effect is significant. A single deceptive advertisement can now trigger: registration suspension by the Indiana Medical Licensing Board under IC 25-22.5-12.5-6; discipline of the responsible practitioner under IC 25-1-9; and referral to the licensing boards of any other practitioners named in the advertisement. The spa’s registration, which will be searchable in a public database mandated by IC 25-22.5-12.5-4, will also carry any disciplinary history — giving plaintiffs’ attorneys and consumer advocates a permanent, consolidated view of the facility’s record.

The Health Care Provider Advertising Statute (IC 25-1-10.3)

The cross-cutting health care provider advertising statute imposes two core obligations on any advertisement that names a practitioner. First, the advertisement must prominently identify the practitioner’s license type — physician (MD/DO), physician assistant, APRN, RN, or esthetician — in a font and style that is readily apparent to the reader. Second, the advertisement may not include any deceptive or misleading information, a standard defined broadly under IC 25-1-10.3-3 to capture implied misrepresentations as well as express ones.

These obligations are self-actuating — they apply regardless of whether the spa has completed its Medical Licensing Board r

egistration, and violations are enforceable by each named practitioner’s respective licensing board. This means an esthetician whose bio overstates her qualifications on the spa’s website faces discipline from the State Board of Cosmetology & Barber Examiners independently of any action taken against the facility.

Medical Licensing Board Rules: What Physicians, PAs, and APRNs Must Know

The Medical Licensing Board’s advertising authority is the broadest of the three boards. IC 25-1-9-4(a)(1)(C) provides that any practitioner who has advertised services in a false or misleading manner is subject to discipline, including license revocation, suspension, censure, and fines. The Board’s administrative rules add further specificity:

• 844 IAC 5-2-13 prohibits advertising calculated to deceive and links advertising-based discipline to the full Standards of Professional Conduct and Competent Practice of Medicine.
• 844 IAC 5-2-22 strictly limits the use of the term “board certified” to credentials issued by recognized specialty boards. Titles like “expert injector” or “advanced cosmetic specialist,” while common in the industry, risk discipline if a reasonable consumer would interpret them as conveying specialty board certification.
• 844 IAC 5-4-1 prohibits a physician from advertising to provide any legend drug outside of an established physician-patient relationship — directly relevant to “Botox party” promotions and online prescribing platforms.

Physician assistants face an additional constraint under 844 IAC 2.2-2-6(10), which prohibits advertising that would mislead the public about a PA’s role and status — a particularly common issue where PAs hold doctoral degrees and advertise using a “Dr.” title without adequate disclosure.

The Pharmacy Board and Compounded-Drug Advertising

For any medical spa advertising services involving compounded medications — GLP-1 weight-loss preparations, peptide therapy, hormone optimization, or IV nutrient infusions — the Indiana Board of Pharmacy introduces a parallel and potentially broader layer of exposure.

Effective July 1, 2026, IC 16-42-22.5 prohibits compounding unless the bulk drug substance meets strict sourcing, testing, and certificate-of-analysis requirements. Promotions for non-compliant compounded products will be captured in the State’s biannual oversight reports, published each March 1 and September 1. More critically, patient-facing claims that compounded semaglutide is “the same as Ozempic” or that any compounded product is “FDA-approved” or “pharmaceutical-grade” are deceptive under both state and federal law — regardless of the advertiser’s intent.

Federal misbranding rules under 21 U.S.C. § 352 and prescription drug advertising regulations at 21 C.F.R. Part 202 are incorporated into Indiana’s pharmacy regulatory framework through 856 IAC 1-20-1. Spa operators should also be aware that 503A compounding pharmacies are restricted under federal law from advertising specific compounded drug products directly to consumers, and that state enforcement piggybacks on those federal restrictions.

The Cosmetology Board: Esthetician Advertising and Scope Bleed

The Indiana Board of Cosmetology & Barber Examiners is the lightest-touch of the three boards but is responsible for a disproportionate share of compliance entanglement. Under IC 25-1-11-5, cosmetology licensees — including estheticians — are subject to the same false-or-misleading advertising prohibition that governs medical practitioners. The problem arises when an esthetician’s service descriptions drift into medical territory.

An esthetician advertising “advanced injection facials,” “medical-grade chemical peels,” or microneedling beyond the scope defined in IC 25-8-2-9.5 exposes herself to Board discipline and simultaneously triggers the facility’s institutional exposure under the three-board framework. Physicians, RNs, and PAs performing cosmetology in the course of medical practice are exempt from cosmetology licensure under IC 25-8-4-1 — but that exemption does not authorize them to advertise using protected cosmetology titles or describe services outside their own scope of practice.

Common Medical Spa Advertising Pitfalls in Indiana — and How to Avoid Them

Indiana medical spa advertising compliance failures tend to cluster around the same recurring categories. Operators who address these proactively before the January 2027 enforcement date will be in a substantially stronger position:

• Provider title misuse. Using “Dr.” for DNP, PharmD, or other non-physician doctorate holders without clear disclosure; using “specialist” or “expert” without recognized board certification. Every named provider’s license type must appear prominently on every services page and in all advertising materials.
• “FDA approved” and “pharmaceutical grade” claims for compounded products. Compounded drugs are not FDA-approved. These claims create state-law misrepresentation exposure and are reportable in the State’s biannual oversight reports.
• Before-and-after photos without HIPAA authorization. Every patient image used in advertising requires a HIPAA-compliant authorization under 45 C.F.R. § 164.508 and IC 16-39-1. Stock images implied to be the spa’s own results are independently deceptive.
• Influencer and testimonial disclosure failures. Paid or comped influencers posting without clear #ad disclosure violate FTC Endorsement Guide requirements under 16 C.F.R. Part 255. Material connection disclosures apply even to services provided in exchange for content.
• Off-site service advertising. IC 25-22.5-12.5-7 prohibits providing services outside the registered medical spa location, a physician’s office, or another licensed health care facility. Advertising mobile, in-home, or pop-up services is, after January 1, 2027, prima facie evidence of unlawful operation.
• Bait-and-switch pricing. Advertising “Botox $9/unit” while applying in-clinic minimums or mandatory add-on services that dramatically inflate the actual cost violates the Indiana Deceptive Consumer Sales Act under IC 24-5-0.5-3.
• Group-buy and referral bonus programs. Group-buy platform commissions structured as a percentage of services performed may constitute prohibited referral fees under 844 IAC 5-2-11. If such platforms are used, fees should be flat rather than service-based.

Medical Spa Advertising in Indiana: How Keffer Hirschauer LLP Can Help

Our attorneys represent licensed physicians, APRNs, physician assistants, estheticians, and other healthcare professionals facing professional license defense matters before Indiana’s licensing boards. As medical spa regulation expands under Indiana Senate Enrolled Act 282, the intersection of facility compliance and individual professional licensing creates compounded risk that demands careful legal guidance.

Whether you are a medical spa operator building a pre-registration compliance program, a responsible practitioner assessing your advertising exposure, or a licensed esthetician concerned about how your employer’s marketing affects your own license, our attorneys understand the three-board framework and what it takes to protect your registration, licensure, and livelihood before enforcement begins.

The compliance window is open now. Registration applications are expected to open in October 2026, with full enforcement on January 1, 2027. Any advertising complaint filed after July 1, 2026 will be assessed under the new statutory standard — regardless of when the underlying creative was produced. Operators who wait for the deadline to review their marketing materials will find themselves forced to choose between emergency restructuring and a disciplinary record that becomes part of the public database permanently.

Contact us today at 317-648-9560 to discuss your case or complete our online contact form to schedule a consultation.